Last reviewed · How we verify
Progressive Pulmonary Fibrosis
Approved treatments
- Jascayd · Boehringer Ingelheim
Jascayd works by inhibiting the activity of phosphodiesterase 4, an enzyme involved in the inflammatory response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Progressive Pulmonary Fibrosis patent landscape — cliff calendar, originator estates, attackable patents
- Progressive Pulmonary Fibrosis treatment landscape brief
- Progressive Pulmonary Fibrosis treatment updates RSS
Frequently asked questions about Progressive Pulmonary Fibrosis
What drugs treat Progressive Pulmonary Fibrosis?
Tracked treatments include Jascayd.
What is the treatment for Progressive Pulmonary Fibrosis?
Standard treatment for Progressive Pulmonary Fibrosis includes Jascayd. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Progressive Pulmonary Fibrosis patent cliff · Progressive Pulmonary Fibrosis CI report
- Treatment: Jascayd · Boehringer Ingelheim
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing